Medivolve Announces CAN $1.2 Million Convertible Note Financing
Summary
Each Warrant will entitle the holder thereof to acquire one common share of the Company at a price of CAN $0.50 for a period of five years following the closing date of the offering. Our network of retail collection sites play an important role in recovery by giving Americans access to fast, accurate, and inexpensive clinical services when and where they need it. Our team is united by a powerful, singular purpose: harnessing the transformative power of technology to create healthier lives.Underpinned by a bespoke, AI-driven platform, were developing a system that constantly gets smarter, takes the guesswork out of diagnostics, and flags critical health issues to help physicians, delivering a high level of personalization for each patient.This press release contains forwardlooking information within the meaning of applicable Canadian securities legislation. Forwardlooking information includes, but is not limited to, statements regarding the convertible note financing, the anticipated use of proceeds and the expected closing date, and the Companys future plans. Forwardlooking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forwardlooking information, including but not limited to: general business, economic, competitive, political and social uncertainties; accidents, labour disputes and shortages and other risks of the healthcare industry.